Megamika 25mg Injection
Marketer
Mapra Laboratories Pvt Ltd
Salt Composition
Amikacin (25mg)
Overview Megamika 25mg Injection
Mikamycin 25mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone and joint, pulmonary (including pneumonia), cerebral, and bloodstream infections, among others. Prophylactic use is also indicated in hospitalized patients. Mikamycin 25mg Injection inhibits bacterial proliferation. Administered intravenously (IV infusion) or intramuscularly by a healthcare professional, self-administration is strictly prohibited. Consistent dosing at prescribed intervals is crucial; complete the entire course, regardless of symptom improvement. Premature cessation risks infection recurrence or exacerbation. Typical side effects involve injection site reactions and elevated blood urea nitrogen (BUN). Persistent side effects or treatment ineffectiveness warrant immediate medical attention. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Adhere strictly to your physician's instructions, including potential monitoring via kidney function, hearing, and urine tests. Pregnancy is a contraindication; disclose pregnancy, pregnancy planning, or breastfeeding to your doctor.
Primary Ingredients of Megamika 25mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Megamika 25mg Injection
Infections caused by bacteria
Major Benefits of Megamika 25mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Megamika 25mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Megamika 25mg Injection:
Administering this medication will be done by your healthcare provider; please do not attempt self-medication.
How Megamika 25mg Injection works:
Megamika 25mg Injection is a bacterial growth inhibitor, functioning as an antibiotic by blocking the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Megamika 25mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Megamika 25mg Injection during pregnancy is contraindicated due to confirmed risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
Lactational use of Megamika 25mg Injection presents minimal risk. Research in humans indicates negligible transfer to breast milk, posing no discernible threat to the infant.
DrivingUNSAFE
Administering Megamika 25mg Injection might induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCAUTION
Individuals with impaired kidney function should use the 25mg Megamika Injection cautiously. A modified dosage of Megamika 25mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Megamika 25mg Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Megamika 25mg Injection :
Should you forget a scheduled dose of Megamika 25mg Injection, seek medical advice.
Facts to Know About Megamika 25mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavior Class | Aminoglycoside antibiotics |
3,018 People bought this recently